Bioconjugates of 103Pd nanostructures for targeted Auger electron therapy.

2022/45/B/ST5/01861

Keywords

Descriptors

  • ST5_010: Materiały /nanomateriały funkcjonalne, nanocząstki
  • ST4_018: Chemia jądrowa i radiacyjna
  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

ST5 – Materials: materials synthesis, structure-properties relations, advanced and functional materials with designed properties, (macro)molecular architecture, material engineering

Host institution

Instytut Chemii i Techniki Jądrowej

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Agnieszka Majkowska-Pilip

Number of co-investigators in the project: 5

Call

OPUS 23 – announced on 2022-03-28

Amount awarded
1 228 400 PLN
Project start date
2023-02-02
Project end date
2026-02-01
Project duration
36 months (the same as in the proposal)
Project status
Project completed

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (3)

  1. Au@109Pd Core–Shell Nanoparticles Conjugated to Panitumumab for the Combined β−—Auger Electron Therapy of Triple-Negative Breast Cancer

    Authors:
    N. Abassi Gharibkandi, A. Majkowska-Pilip, R. Walczak, M. Wierzbicki, A. Bilewicz
    Academic press:
    Int. J. Mol. Sci. (year: 2024, volume: 24(25), pages: 13555), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms252413555 – link to the publication
  2. 109Pd/109mAg in-vivo generator in the form of nanoparticles for combined β- - Auger electron therapy of hepatocellular carcinoma

    Authors:
    Nasrin Abbasi Gharibkandi, Kamil Wawrowicz, Rafał Walczak, Agnieszka Majkowska-Pilip, Mateusz Wierzbicki & Aleksander Bilewicz
    Academic press:
    EJNMMI Radiopharmacy and Chemistry (year: 2024, volume: 9, pages: 59-82), Publisher: Springer Open
    Status:
    Published
    DOI:
    10.1186/s41181-024-00293-9 – link to the publication
  3. Au@109Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of 109Pd/109mAg in vivo generator in combined β- auger electron therapy

    Authors:
    N. A. Gharibkandi, K. Wawrowicz, A. Majkowska‑Pilip, K. Żelechowska‑Matysiak, M. Wierzbicki and A. Bilewicz
    Academic press:
    EJNMMI Radiopharm Chem . (year: 2023, volume: 8, pages: 26-42), Publisher: Springer Nature Switzerland AG
    Status:
    Published
    DOI:
    10.1186/s41181-023-00212-4 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski